Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
35.27
35.27
35.27
21.44
10.27
Share Warrants & Outstandings
Total Reserve
12.39
24.05
36.78
0.67
-1.60
Shareholder's Funds
47.65
59.32
72.05
22.46
8.67
Minority Interest
-0.05
-4.28
-1.55
0.00
0.00
Long-Term Borrowings
11.84
30.18
3.59
0.00
0.00
Secured Loans
3.35
2.33
0.00
0.00
0.00
Unsecured Loans
8.49
27.85
3.59
0.00
0.00
Deferred Tax Assets / Liabilities
-12.28
-10.50
-6.67
-2.71
-0.36
Other Long Term Liabilities
3.63
5.14
5.07
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.18
0.78
0.62
0.00
0.00
Total Non-Current Liabilities
3.37
25.59
2.60
-2.71
-0.36
Current Liabilities
Trade Payables
2.78
16.32
5.12
1.88
2.31
Other Current Liabilities
12.11
7.24
4.61
0.24
0.13
Short Term Borrowings
9.07
5.06
1.77
0.00
0.00
Short Term Provisions
0.05
0.10
0.08
0.00
0.00
Total Current Liabilities
24.01
28.71
11.58
2.13
2.44
Total Liabilities
74.98
109.35
84.67
21.88
10.76
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
55.19
76.63
62.08
0.12
0.51
Less: Accumulated Depreciation
3.52
3.63
1.78
0.02
0.48
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
51.67
73.00
60.30
0.11
0.03
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
6.10
4.53
7.00
2.00
0.45
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
2.23
5.90
0.72
1.47
6.19
Other Non Current Assets
33.14
32.74
0.00
0.79
1.42
Total Non-Current Assets
63.99
88.36
71.14
4.37
8.09
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
3.31
0.00
Inventories
0.41
12.18
3.59
0.00
0.89
Sundry Debtors
3.43
3.13
2.68
1.39
1.34
Cash and Bank
0.13
0.82
4.80
12.75
0.41
Other Current Assets
3.91
0.40
0.16
0.00
0.00
Short Term Loans and Advances
3.11
4.45
2.30
0.07
0.03
Total Current Assets
10.99
20.99
13.53
17.51
2.67
Net Current Assets (Including Current Investments)
-13.02
-7.73
1.96
15.39
0.23
Total Current Assets Excluding Current Investments
10.99
20.99
13.53
14.21
2.67
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.12
0.00
Total Assets
74.98
109.35
84.67
21.88
10.76
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
Total Debt
20.91
35.25
5.35
0.00
0.00
Book Value per share (adjusted)
13.51
16.82
20.43
10.31
8.44
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -40.68% vs 558.88% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -29.38% vs 1.38% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -25.49% vs 15.20% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -47.64% vs 55.14% in Mar 2025
Compare Balance Sheet Results of Pharmaids Pharma
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
35.27
0
35.27
0.00%
Share Warrants & Outstandings
Total Reserve
12.39
0
12.39
0.00%
Shareholder's Funds
47.65
0
47.65
0.00%
Minority Interest
-0.05
0
-0.05
0.00%
Long-Term Borrowings
11.84
0
11.84
0.00%
Secured Loans
3.35
0
3.35
0.00%
Unsecured Loans
8.49
0
8.49
0.00%
Deferred Tax Assets / Liabilities
-12.28
0
-12.28
0.00%
Other Long Term Liabilities
3.63
0
3.63
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.18
0
0.18
0.00%
Total Non-Current Liabilities
3.37
0
3.37
0.00%
Current Liabilities
Trade Payables
2.78
0
2.78
0.00%
Other Current Liabilities
12.11
0
12.11
0.00%
Short Term Borrowings
9.07
0
9.07
0.00%
Short Term Provisions
0.05
0
0.05
0.00%
Total Current Liabilities
24.01
0
24.01
0.00%
Total Liabilities
74.98
0
74.98
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
55.19
0
55.19
0.00%
Less: Accumulated Depreciation
3.52
0
3.52
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
51.67
0
51.67
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
6.10
0
6.10
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
2.23
0
2.23
0.00%
Other Non Current Assets
33.14
0
33.14
0.00%
Total Non-Current Assets
63.99
0
63.99
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
0.41
0
0.41
0.00%
Sundry Debtors
3.43
0
3.43
0.00%
Cash and Bank
0.13
0
0.13
0.00%
Other Current Assets
3.91
0
3.91
0.00%
Short Term Loans and Advances
3.11
0
3.11
0.00%
Total Current Assets
10.99
0
10.99
0.00%
Net Current Assets (Including Current Investments)
-13.02
0
-13.02
0.00%
Total Current Assets Excluding Current Investments
10.99
0
10.99
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
74.98
0
74.98
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
20.91
0
20.91
0.00%
Book Value per share (adjusted)
13.51
0
13.51
0.00%
Annual - Borrowings
Borrowings 20.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -40.68% vs 558.88% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 3.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -29.38% vs 1.38% in Mar 2025
Annual - Fixed Assets
Fixed Assets 57.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -25.49% vs 15.20% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.99 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -47.64% vs 55.14% in Mar 2025






